Assessing the Impact of Insulin Resistance Trajectories on Cardiovascular Disease Risk Using Longitudinal Targeted Maximum Likelihood Estimation

Overview

Journal Cardiovasc Diabetol

Publisher Biomed Central

Specialties Cardiology & Vascular Diseases
Endocrinology

Date 2025 Mar 11

PMID 40065358

Authors

Yaning Feng

Liangying Yin

Haoran Huang

Yongheng Hu

Sitong Lin

Affiliations

Soon will be listed here.

Abstract

Background: Cardiovascular disease (CVD) is closely associated with Insulin Resistance (IR). However, there is limited research on the relationship between trajectories of IR and CVD incidence, considering both time-invariant and time-varying confounders. We employed advanced causal inference methods to evaluate the longitudinal impact of IR trajectories on CVD risk.

Methods: The data for this study were extracted from a Chinese nationwide cohort, named China Health and Retirement Longitudinal Study (CHARLS). Triglyceride-glucose (TyG) index and TyG body mass index (BMI) were used as surrogate markers for IR, and their changes were recorded as exposures. Longitudinal targeted maximum likelihood estimation (LTMLE) was used to study how dynamic shifts in IR trajectories (i.e., increase, decrease, etc.) influence long-term CVD risk, adjusting for both time-invariant and time-varying confounders.

Results: A total of 3,966 participants were included in the analysis, with 2,152 (54.3%) being female. The average age at baseline was 58.28 years. Over the course of a 7-year follow-up period, 499 (12.6%) participants developed CVD. Four distinct trajectories of TyG index and TyG-BMI were identified: low stable, increasing, decreasing, and high stable. LTMLE analyses revealed individuals in the 'high stable' and 'increasing' groups had a significantly higher risk of developing CVD compared to those in the 'low stable' group, while the 'decreasing' group showed no significant differences. Specifically, when the exposure was set as TyG-BMI, the odds of CVD in the 'high stable' group were 1.694 (95% CI: 1.361-2.108) times higher than in the 'low stable' group. Similar trends were observed across other models, with ORs of 1.708 (95% CI: 1.367-2.134) in Model 2, 1.389 (1.083-1.782) in Model 3, 1.675 (1.185-2.366) in Model 4, and 1.375 (95% CI:1.07 - 1.768) in Model 5. When the exposure was changed to the TyG index, the results remained consistent, with a slightly lower magnitude of the odds ratios.

Conclusions: High stable and increasing TyG-BMI and TyG index trajectories were associated with the risk of CVD. TyG-BMI consistently exhibited higher odds ratios (ORs) of CVD risk when comparing with TyG index. Early identification of IR trajectories could provide insights for preventing CVD later in life.

References

Luo P, Cao Y, Li P, Li W, Song Z, Fu Z . TyG Index Performs Better Than HOMA-IR in Chinese Type 2 Diabetes Mellitus with a BMI < 35 kg/m2: A Hyperglycemic Clamp Validated Study. Medicina (Kaunas). 2022; 58(7). PMC: 9325243. DOI: 10.3390/medicina58070876. View

Kosmas C, Bousvarou M, Kostara C, Papakonstantinou E, Salamou E, Guzman E . Insulin resistance and cardiovascular disease. J Int Med Res. 2023; 51(3):3000605231164548. PMC: 10069006. DOI: 10.1177/03000605231164548. View

Wang W, Liu Y, Liu J, Yin P, Wang L, Qi J . Mortality and years of life lost of cardiovascular diseases in China, 2005-2020: Empirical evidence from national mortality surveillance system. Int J Cardiol. 2021; 340:105-112. DOI: 10.1016/j.ijcard.2021.08.034. View

Lee J, Jeon S, Joung B, Lee H, Kwon Y . Associations of Homeostatic Model Assessment for Insulin Resistance Trajectories With Cardiovascular Disease Incidence and Mortality. Arterioscler Thromb Vasc Biol. 2023; 43(9):1719-1728. DOI: 10.1161/ATVBAHA.123.319200. View

Hu Y, Zhao Y, Zhang J, Li C . The association between triglyceride glucose-body mass index and all-cause mortality in critically ill patients with atrial fibrillation: a retrospective study from MIMIC-IV database. Cardiovasc Diabetol. 2024; 23(1):64. PMC: 10859027. DOI: 10.1186/s12933-024-02153-x. View

Feng G, Yang M, Xu L, Liu Y, Yu J, Zang Y . Combined effects of high sensitivity C-reactive protein and triglyceride-glucose index on risk of cardiovascular disease among middle-aged and older Chinese: Evidence from the China Health and Retirement Longitudinal Study. Nutr Metab Cardiovasc Dis. 2023; 33(6):1245-1253. DOI: 10.1016/j.numecd.2023.04.001. View

Raimi T, Dele-Ojo B, Dada S, Fadare J, Ajayi D, Ajayi E . Triglyceride-Glucose Index and Related Parameters Predicted Metabolic Syndrome in Nigerians. Metab Syndr Relat Disord. 2020; 19(2):76-82. PMC: 7929914. DOI: 10.1089/met.2020.0092. View

Son D, Lee H, Lee Y, Lee J, Han J . Comparison of triglyceride-glucose index and HOMA-IR for predicting prevalence and incidence of metabolic syndrome. Nutr Metab Cardiovasc Dis. 2022; 32(3):596-604. DOI: 10.1016/j.numecd.2021.11.017. View

Xu W, Zhao H, Gao L, Guo L, Liu J, Li H . Association of long-term triglyceride-glucose index level and change with the risk of cardiometabolic diseases. Front Endocrinol (Lausanne). 2023; 14:1148203. PMC: 10098344. DOI: 10.3389/fendo.2023.1148203. View

10.

Robins J, Hernan M, Brumback B . Marginal structural models and causal inference in epidemiology. Epidemiology. 2000; 11(5):550-60. DOI: 10.1097/00001648-200009000-00011. View

11.

van der Laan M . Targeted maximum likelihood based causal inference: Part I. Int J Biostat. 2011; 6(2):Article 2. PMC: 3126670. View

12.

Cui C, Liu L, Zhang T, Fang L, Mo Z, Qi Y . Triglyceride-glucose index, renal function and cardiovascular disease: a national cohort study. Cardiovasc Diabetol. 2023; 22(1):325. PMC: 10685637. DOI: 10.1186/s12933-023-02055-4. View

13.

Lee J, Jeon S, Lee H, Lee J . Trajectories of triglyceride-glucose index changes and their association with all-cause and cardiovascular mortality: a competing risk analysis. Cardiovasc Diabetol. 2024; 23(1):364. PMC: 11481394. DOI: 10.1186/s12933-024-02457-y. View

14.

Zhao Y, Hu Y, Smith J, Strauss J, Yang G . Cohort profile: the China Health and Retirement Longitudinal Study (CHARLS). Int J Epidemiol. 2012; 43(1):61-8. PMC: 3937970. DOI: 10.1093/ije/dys203. View

15.

Su X, Zhao C, Zhang X . Association between METS-IR and heart failure: a cross-sectional study. Front Endocrinol (Lausanne). 2024; 15:1416462. PMC: 11249535. DOI: 10.3389/fendo.2024.1416462. View

16.

Li F, Zhang L, Shen Y, Liu H, Zhang Z, Hu G . Higher glucose fluctuation is associated with a higher risk of cardiovascular disease: Insights from pooled results among patients with diabetes. J Diabetes. 2023; 15(5):368-381. PMC: 10172020. DOI: 10.1111/1753-0407.13386. View

17.

Adeva-Andany M, Martinez-Rodriguez J, Gonzalez-Lucan M, Fernandez-Fernandez C, Castro-Quintela E . Insulin resistance is a cardiovascular risk factor in humans. Diabetes Metab Syndr. 2019; 13(2):1449-1455. DOI: 10.1016/j.dsx.2019.02.023. View

18.

Simental-Mendia L, Rodriguez-Moran M, Guerrero-Romero F . The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord. 2008; 6(4):299-304. DOI: 10.1089/met.2008.0034. View

19.

Spitler K, Davies B . Aging and plasma triglyceride metabolism. J Lipid Res. 2020; 61(8):1161-1167. PMC: 7397742. DOI: 10.1194/jlr.R120000922. View

20.

Petersen N, Kodali S, Meng C, Li F, Nguyen C, Peshwe K . Blood Pressure Trajectory Groups and Outcome After Endovascular Thrombectomy: A Multicenter Study. Stroke. 2021; 53(4):1216-1225. PMC: 8960326. DOI: 10.1161/STROKEAHA.121.034408. View